MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$679K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts payable
Accrued expenses
Change in right-of-use assets
Others
Negative Cash Flow Breakdown
Selling, general and administrat...
Cost of goods sold
Inventory
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total net revenues
6,017
5,212
4,729
14,060
Cost of goods sold
1,991
2,219
1,968
5,196
Gross margin
4,026
2,993
2,761
8,864
Research and development
366
346
395
944
Selling, general and administrative
2,418
2,521
2,316
6,684
Other operating expenses
29
29
32
108
Total operating expenses
2,813
2,896
2,743
7,736
Operating income
1,213
97
18
1,128
Total other income (expense)
-3
43
44
16
Income (loss) before income taxes
-
-
-
1,144
Income tax expense
13
-
0
12
Net income
1,197
140
62
337
Depreciation of property and equipment
12
11
13
12
Amortization of intangible assets, license and supply agreement and finance lease right-of-use asset
16
16
19
22
Stock-based compensation
61
60
79
70
Inventory impairments and write offs
11
11
12
15
Change in right-of-use assets
96
93
356
-
Provision for credit losses
2
-
-
-
(gain) loss on foreign currency transactions
-4
13
-6
8
Accounts receivable
577
1,107
-247
621
Inventory
939
398
506
516
Prepaid expenses and other current assets
-82
161
41
-91
Right-of-use assets
-
-
-
-90
Accounts payable
499
562
-29
312
Accrued expenses
311
-791
367
380
Lease liabilities
-94
-94
-90
-85
Net cash (used in) provided by operating activities
681
-1,671
230
99
Net cash used in investing activities
-
-
0
-
Proceeds from exercise of options
0
290
-
-
Principal payments on finance lease liability
2
1
1
2
Net cash provided by (used in) financing activities
-2
289
-1
-2
Net (decrease) increase in cash and cash equivalents
679
-1,382
229
97
Cash and cash equivalents, beginning of period
4,018
5,400
5,171
3,760
Cash and cash equivalents, end of period
4,697
4,018
5,400
5,171
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Total net revenues
$6,017K
Gross margin
$4,026K
Canceled cashflow
$1,991K
Operating income
$1,213K
Canceled cashflow
$2,813K
Cost of goods sold
$1,991K
Net income
$1,197K
(50.57%↑ Y/Y)
Accounts payable
$499K
(2179.17%↑ Y/Y)
Accrued expenses
$311K
(12.27%↑ Y/Y)
Change in right-of-use
assets
$96K
Prepaid expenses and
other current assets
-$82K
(-196.47%↓ Y/Y)
Stock-based compensation
$61K
(-58.50%↓ Y/Y)
Amortization of intangible
assets, license and...
$16K
(-62.79%↓ Y/Y)
Depreciation of property and
equipment
$12K
(-60.00%↓ Y/Y)
Inventory impairments and
write offs
$11K
(-73.17%↓ Y/Y)
(gain) loss on foreign
currency transactions
-$4K
(42.86%↑ Y/Y)
Provision for credit
losses
$2K
Canceled cashflow
$16K
Total operating
expenses
$2,813K
Net cash (used in)
provided by operating...
$681K
(-48.25%↓ Y/Y)
Canceled cashflow
$1,610K
Income tax expense
$13K
Total other income
(expense)
-$3K
Selling, general and
administrative
$2,418K
Research and development
$366K
Other operating
expenses
$29K
Net (decrease)
increase in cash and cash...
$679K
(-48.33%↓ Y/Y)
Canceled cashflow
$2K
Inventory
$939K
(378.64%↑ Y/Y)
Accounts receivable
$577K
(122.78%↑ Y/Y)
Lease liabilities
-$94K
(44.05%↑ Y/Y)
Net cash provided by
(used in) financing...
-$2K
(0.00%↑ Y/Y)
Principal payments on
finance lease liability
$2K
(0.00%↑ Y/Y)
Buy us a coffee
NEPHROS INC (NEPH)
NEPHROS INC (NEPH)